186 related articles for article (PubMed ID: 14713176)
1. Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
Alexopoulos GP; Anastasiou-Nana MI; Rapti ACh; Margari ZJ; Terrovitis JV; Mitsibounas D; Makri S; Nanas JN
Acta Cardiol; 2003 Dec; 58(6):513-7. PubMed ID: 14713176
[TBL] [Abstract][Full Text] [Related]
2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
5. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.
Kapelios CJ; Kaldara E; Ntalianis A; Nana E; Pantsios C; Repasos E; Margari Z; Sousonis V; Malliaras K; Nanas JN
Int J Cardiol; 2014 Dec; 177(2):690-2. PubMed ID: 25304067
[No Abstract] [Full Text] [Related]
6. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of diuretic dose in chronic heart failure.
Martins J; Lourenço P; Araújo JP; Mascarenhas J; Lopes R; Azevedo A; Bettencourt P
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):185-91. PubMed ID: 21335479
[TBL] [Abstract][Full Text] [Related]
8. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
10. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
11. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
da Rosa PR; Rohde LE; Doebber M; Ribeiro ALP; Prado DP; Bertoldi EG; Figueiredo Neto JA; Kohler I; Beck-da-Silva L; Danzmann LC; Moura LZ; Rover M; Simões MV; Sant'Anna RT; Biolo A
Am Heart J; 2017 Dec; 194():125-131. PubMed ID: 29223430
[TBL] [Abstract][Full Text] [Related]
12. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
13. The prognostic implications of outpatient diuretic dose in heart failure.
Harjai KJ; Dinshaw HK; Nunez E; Shah M; Thompson H; Turgut T; Ventura HO
Int J Cardiol; 1999 Dec; 71(3):219-25. PubMed ID: 10636527
[TBL] [Abstract][Full Text] [Related]
14. Dose-ranging study of isosorbide-5-mononitrate in chronic congestive heart failure treated with diuretics and angiotensin-converting enzyme inhibitor.
Debbas N; Woodings D; Marks C; Bhans A; Jubber A; Dews I; Stephens J; Vandenburg M
Am J Cardiol; 1988 Mar; 61(9):28E-30E. PubMed ID: 2831702
[TBL] [Abstract][Full Text] [Related]
15. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
Dormans TP; Gerlag PG
Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
[TBL] [Abstract][Full Text] [Related]
16. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance.
Chomsky DB; Lang CC; Rayos G; Wilson JR
J Heart Lung Transplant; 1997 Aug; 16(8):846-53. PubMed ID: 9286777
[TBL] [Abstract][Full Text] [Related]
17. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
[TBL] [Abstract][Full Text] [Related]
18. Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function.
van Kraaij DJ; Jansen RW; Bouwels LH; Hoefnagels WH
Arch Intern Med; 1999 Jul; 159(14):1599-605. PubMed ID: 10421283
[TBL] [Abstract][Full Text] [Related]
19. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
20. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
Imiela T; Budaj A
Clin Drug Investig; 2017 Dec; 37(12):1175-1181. PubMed ID: 28965280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
